Executive Director, Global Commercial Precision Medicine & Companion Diagnostics

Accountabilities

• Lead the development and execution of global precision medicine strategies aligned with portfolio objectives, including biomarker positioning, patient identification, testing pathways, and diagnostic solutions.
• Partner with Clinical Development, Medical Affairs, Market Access, Regulatory, Translational Medicine, Business Development, and regional commercial teams to build integrated companion diagnostic strategies.
• Ensure global readiness for companion diagnostic development, regulatory milestones, launch execution, commercialization, and lifecycle planning across key markets.
• Develop diagnostic roadmaps, launch strategies, market readiness assessments, testing forecasts, and investment recommendations to support portfolio decisions.
• Collaborate with Market Access teams to create evidence-generation and health technology assessment strategies that improve diagnostic and patient access.
• Drive market development initiatives focused on biomarker education, stakeholder engagement, and adoption of appropriate testing approaches.
• Establish and manage strategic partnerships with diagnostic companies, laboratory networks, technology providers, professional organizations, and other external stakeholders.
• Build scalable diagnostic capabilities and resources to support long-term organizational growth and commercial success.
• Define and monitor key performance indicators related to testing adoption, diagnostic access, launch readiness, and commercial performance.
• Provide executive-level guidance on opportunities to improve patient identification, strengthen market differentiation, and maximize portfolio value.
• Leverage digital tools, data analytics, and innovative commercial approaches to enhance biomarker testing and customer engagement.
• Travel requirements may be up to 50%.

Requirements

• Bachelor's degree required; advanced scientific degree (MS, PhD, PharmD) and/or MBA preferred.
• 15+ years of progressive experience within the biotechnology or pharmaceutical industry, including significant leadership experience in precision medicine, companion diagnostics, oncology commercialization, or related areas.
• Demonstrated success developing and implementing global precision medicine strategies supporting product development, launch preparation, and lifecycle management.
• Experience working with companion diagnostic manufacturers, laboratory networks, diagnostic partners, and healthcare stakeholders.
• Strong understanding of companion diagnostic development, regulatory pathways, laboratory medicine, reimbursement environments, and global testing ecosystems.
• Proven ability to translate scientific, clinical, regulatory, and market insights into impactful commercial strategies.
• Experience leading cross-functional initiatives and influencing senior stakeholders across global, matrixed organizations.
• Strong leadership skills with the ability to build teams, establish new capabilities, and drive alignment without direct authority.
• Excellent communication, organizational, and strategic planning skills with the ability to manage multiple priorities in a fast-paced environment.
• Entrepreneurial mindset with the ability to operate effectively in evolving environments and a passion for advancing cancer care.

Preferred Qualifications

• Biomarker-defined solid tumors
• Targeted therapies
• Rapidly growing biotechnology organizations
• Global laboratory networks
• External diagnostic partnerships

Benefits

• Competitive base salary range of approximately $252,000-$315,000 USD, depending on location, experience, skills, and qualifications.
• Comprehensive total rewards package including competitive cash compensation, equity opportunities, and performance-based programs.
• Robust healthcare and employee benefits designed to support physical, financial, and overall well-being.
• Opportunities for professional growth, continuous learning, and leadership development.
• Flexible work environment, including remote eligibility where applicable.
• Opportunity to contribute to innovative oncology programs focused on improving outcomes for patients with cancer.
• Collaborative culture with experienced professionals across scientific, clinical, and commercial disciplines.